Form 4: Relay Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Brian Adams, Chief Legal Officer of Relay Therapeutics, sold 295 shares of common stock on September 27, 2024, to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On September 27, 2024, Brian Adams, the Chief Legal Officer of Relay Therapeutics, Inc. (RLAY), sold 295 shares of common stock.
- The sale was executed at a price of $7.51 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 992 restricted stock units (RSUs) on September 26, 2024.
- Following the transaction, Adams beneficially owns 323,539 shares of Relay Therapeutics, Inc., which includes 283,831 shares underlying RSUs.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock sale to cover tax obligations, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a small sale of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/26/2024 | Vesting of 992 shares of restricted stock units (RSUs). |
| 09/27/2024 | Sale of 295 shares of common stock by Brian Adams. |
| 10/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.